Thursday, February 26, 2015

Massachusetts Health Care Companies 2014 Earnings Were $5.409 Bil, Up 92% Over 2013

Since Elizabeth Warren is trying to decide whether to run for US President in 2016, I think it would be helpful to research just how her home state of Massachusetts has been doing since the 2008 Financial Meltdown.  She has worked very hard to help Massachusetts and the entire country recover from this horrific financial mess.

From a very thorough review of SEC filings, I found a large number of 22 Health Care Companies headquartered in Massachusetts with Stock Market Capitalizations of at least $1 bil now or when they were recently sold and which have had their common stock trading since December 31, 2007.

Of these 22 Massachusetts Companies, 18 of them have filed financial statements with the SEC, predominantly audited, where annual information was supplied for all fiscal years from 2007 through 2014.  The other 4 haven't filed their December 2014 financial statements yet with the SEC.

These 18 Massachusetts Health Care Companies generated  Total Net Income From Continuing Operations for their 2014 fiscal years of $5.409 bil, which was an incredibly off-the-charts 92% above their comparable Total Earnings only one year earlier in 2013.

Below here are the Earnings (Losses) of each of these 18 Massachusetts Health Care Companies in both 2014 and 2013:





2014



Earnings



2014 2013 Better
Massachusetts
Net Net (Worse)
Health Care City 2014 Income Income Than
Company HQs FYE (Loss) (Loss) 2013

mil $s mil $s mil $s





Biogen Idec Cambridge Dec          2,942         1,862         1,080
Thermo Fisher Scientific Waltham Dec          1,896         1,279            617
Covidien plc Mansfield Sep          1,662         1,600               62
PerkinElmer Waltham Dec             161            174            (13)
AMAG Pharmaceuticals Waltham Dec             136            (10)            146
Charles River Laboratories Wilmington Dec             130            105               25
PAREXEL Intl Waltham Jun             129               96               33
Haemonetics Braintree Mar                35               39               (4)
Hologic Bedford Sep                17      (1,173)         1,190
ABIOMED Danvers Mar                  7               15               (8)
Dyax Burlington Dec             (12)            (28)               16
Nxstage Medical Lawrence Dec             (24)            (19)               (5)
Celldex Therapeutics Needham Dec           (118)            (82)            (36)
Boston Scientific Natick Dec           (119)          (121)                 2
Ariad Pharmaceuticals Cambridge Dec           (163)          (274)            111
Alere Waltham Dec           (168)            (53)          (115)
Alnylam Pharmaceuticals Cambridge Dec           (360)            (89)          (271)
Vertex Pharmaceuticals Cambridge Dec           (742)          (504)          (238)






Total all 18

         5,409         2,817         2,592






% Earnings Increase 2014 Over 2013

92%